CAPTRUST FINANCIAL ADVISORS - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 8 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q2 2022$3,000
+200.0%
57,659
+182.6%
0.00%
Q1 2022$1,000
-50.0%
20,402
-52.2%
0.00%
Q4 2021$2,000
+100.0%
42,659
+90.0%
0.00%
Q3 2021$1,000
-50.0%
22,4570.0%0.00%
Q2 2021$2,0000.0%22,4570.0%0.00%
Q1 2021$2,000
+100.0%
22,4570.0%0.00%
Q4 2020$1,0000.0%22,457
+3.7%
0.00%
Q2 2020$1,00021,6570.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q1 2021
NameSharesValueWeighting ↓
Schonfeld Group Holdings LLC 15,000$12,0000.09%
Cutter & CO Brokerage, Inc. 94,500$77,0000.03%
PRINCETON CAPITAL MANAGEMENT LLC 25,000$20,0000.02%
STANCORP INVESTMENT ADVISERS INC 14,000$11,0000.01%
WADE G W & INC 30,000$24,0000.01%
B. Riley Wealth Advisors, Inc. 18,000$15,0000.00%
Estate Counselors, LLC 10,000$8,0000.00%
LUPO SECURITIES, LLC 800$1,0000.00%
Virtu KCG Holdings LLC 122,755$100,0000.00%
Commonwealth Equity Services, Inc 80,500$66,0000.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders